Shoreline Biosciences
Christine Huh began their work experience in 2016 as a Senior Scientist at Pfizer. Christine then moved on to UC San Diego in 2018 and La Jolla Institute for Immunology in 2019 as a Postdoctoral Fellow. Currently, they are a Senior Scientist at Shoreline Biosciences, Inc., where they were previously a Senior Scientist before being promoted to Principal Scientist in 2024.
Christine Huh received their Bachelor of Arts in Molecular and Cellular Biology from the University of California, Berkeley. Christine then went on to earn their Doctor of Philosophy in the same field from Washington University in St. Louis.
Shoreline Biosciences
Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.